Research progress on insulin-like growth factor-binding protein-4 as a marker of vulnerable atherosclerotic plaque
CSTR:
Author:
Affiliation:

(1. Department of Cardiology, the First Affiliated Hospital, Air force Medical University, Xi′an 710032, China;2.the Second Medical Center of Chinese PLA General Hospital, 100853, China;3. National Clinical Research Center for Geriatric Diseases, Beijing 100853, China)

Clc Number:

R541.4

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Vulnerable plaque is one of the important risk factors for major adverse cardiovascular events, and its early detection and effective intervention are of great clinical significance. Insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) is a substrate of pregnancy-associated plasma protein-A (PAPP-A) in vulnerable plaques and mediates the release of IGF, which is likely to accelerate atherogenesis. Thus, IGFBP-4 serves as one of the important biomarkers of vulnerable plaque. Vulnerable plaque is the pathologenic basis of acute coronary syndrome and a much sought-after focus in cardiovascular field. In this article, we reviewed the role of IGFBP-4 in the development of vulnerable plaque and its potential in assessing plaque vulnerability and major adverse cardiovascular events.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:October 08,2018
  • Revised:October 27,2018
  • Adopted:
  • Online: January 23,2019
  • Published:
Article QR Code